# Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI

Study · id `cardio:ct-nct02323620` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02323620](<https://clinicaltrials.gov/study/NCT02323620>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02323620

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Heart failure; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT02323620. Randomized; no masking; primary purpose treatment. Start 2019-03 (anticipated); primary completion 2022-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT02323620, source copy `cardio:ctgov-nct02323620-2019-01-23`, retrieved 2026-10-26)
- Planned start: 2019-03 (anticipated) (ClinicalTrials.gov record NCT02323620, source copy `cardio:ctgov-nct02323620-2019-01-23`, retrieved 2026-10-26)
- Primary completion: 2022-07 (anticipated) (ClinicalTrials.gov record NCT02323620, source copy `cardio:ctgov-nct02323620-2019-01-23`, retrieved 2026-10-26)
- Completion: 2022-12 (anticipated) (ClinicalTrials.gov record NCT02323620, source copy `cardio:ctgov-nct02323620-2019-01-23`, retrieved 2026-10-26)
- Countries: Poland (ClinicalTrials.gov record NCT02323620, source copy `cardio:ctgov-nct02323620-2019-01-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02323620-2019-01-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI
- Acronym: RACE-STEMI
- Condition: Heart Failure
- Condition: Myocardial Infarction
- Intervention (Procedure): Intracoronary infusion of BM-MC
- Lead sponsor: American Heart of Poland
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: American Heart of Poland (`cardio:org-american-heart-of-poland`)

## Provenance

Content hash: 27455158d8443e3ad1b82e7d072d7f2e3be2063687feab2b535b792f5ee0c9d5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
